stigma

Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.

ISSUP UK are are pleased to have presented their second Webinar in the DARC Research Webinar Series 2021 on Wednesday 17 February, by Dr Claire Melia on the subject of Language matters: Contemporary discursive constructions of alcohol use.

Public stigma towards people who use substances can impact people seeking support and treatment outcomes. It can also influence how public health policy is shaped and accepted. Researchers have been interested in understanding how people...

Adfam, in collaboration with the University of York, and funded by the Forces in Mind Trust, has published a research report outlining the experiences and needs of families of veterans with substance use problems (FVSUs), along with a new...

While the National BBV/STI Strategies have emphasised the importance of stigma for people who inject drugs. However, until recently there has not been a system to measure and report on the experience of stigma. This presentation will cover...

Dr Liviu Alexandrescu Lecturer in Criminology School of History, Philosophy and Culture – Oxford Brookes University Presentation title: Drug/dependency stigma and marginality: some reflections on the political economy of blame. Dr James...